The company stated that people who sign up for the waitlist will gain priority access to the official debut of Ozempic and Wegovy on the telehealth company’s platform.
Hims & Hers Health Inc. (HIMS) on Wednesday announced a pre-launch waitlist for Ozempic and Wegovy following a partnership with Novo Nordisk AS (NVO).
Add Asianet Newsable as a Preferred Source
Hims & Hers stated that people who sign up for the waitlist will gain priority access to the official debut of Ozempic and Wegovy on the telehealth company’s platform.
Interested users can join the waitlist here or here.
Hims & Hers shares were down nearly 1% in Wednesday’s pre-market trade. Retail sentiment on Stocktwits around the company trended in the ‘bullish’ territory with message volumes at ‘high’ levels at the time of writing.
Get updates to this story developing directly on Stocktwits.<
For updates and corrections, email newsroom[at]stocktwits[dot]com.<
